查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585837

溴病治療市場：依治療方法、依適應症分類 - 全球預測 2025-2030

Bromhidrosis Disease Treatment Market by Treatment (Botox, Liposuction, Surgery), Indication (Erythrasma, Intertrigo, Trichomycosis Axillaries) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年溴病治療市場價值為4.4867億美元，預計2024年將達到4.8903億美元，複合年成長率為9.39%，2030年將達到8.4104億美元。

狐臭，俗稱狐臭，是由大汗腺和小汗腺分泌物細菌分解引起的。治療範圍包括局部和全身治療、生活方式調整，以及晚期病例的手術介入。腋臭治療的必要性因其顯著的社會心理影響而凸顯，影響人際關係和工作互動，刺激了對有效解決方案的需求。這些治療的應用範圍從非處方除臭劑到處方藥再到先進的雷射和外科手術，最終用途包括醫院、專科診所和居家醫療。影響市場成長的主要因素包括個人衛生意識的提高、可支配收入的增加以及治療方法的進步。潛在的治療機會包括開發個人化治療方法、使用生物技術開發新型治療劑以及除臭劑配方中的天然和有機成分，以滿足對環保產品日益成長的需求。然而，由於替代療法的存在、某些藥物相關的副作用以及可能抑制患者參與的文化偏見，該市場面臨著限制。挑戰還包括監管障礙以及與雷射和手術等先進治療相關的高成本。生物技術的創新可能為針對特定細菌的新型抗生素鋪平道路，並提高狐臭治療的有效性。此外，探索微生物組研究和遺傳傾向等領域可能會帶來預防醫學的突破。溴多汗症治療市場競爭激烈，各公司不斷努力創新，同時維持實惠的價格。為了實現業務成長，重點關注消費者教育、擴大我們的分銷網路並促進與皮膚科醫生和醫療保健提供者的合作非常重要。結合數位行銷策略並提供個人化護理選項將進一步提高市場滲透率和消費者忠誠度。

主要市場統計
基準年[2023] 4.4867 億美元
預測年份 [2024] 4.8903億美元
預測年份 [2030] 84104萬美元
複合年成長率（%） 9.39%

市場動態：快速發展的溴病治療市場的關鍵市場洞察

供需的動態交互作用正在改變溴病治療市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 溴多汗症、腎臟和肝臟疾病增加
    • 增加臨床試驗和研發活動的投資
    • 對體臭問題的認知
  • 市場限制因素
    • 治療費用上漲
  • 市場機會
    • 治療產品核准迅速增加
    • 以微波治療腋窩多汗症和腋臭
  • 市場挑戰
    • 產品召回及不良健康影響

波特五力：開拓溴病治療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解溴病治療市場的外部影響

外部宏觀環境因素在塑造溴病治療市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解溴病治療市場的競爭狀況

溴病治療市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣溴病治療市場供應商績效評估

FPNV 定位矩陣是評估溴病治療市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃溴病治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對溴病治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 狐臭、腎臟和肝臟疾病增加
      • 增加臨床試驗和研發活動的投資
      • 對體臭問題的認知
    • 抑制因素
      • 治療費用高
    • 機會
      • 治療產品的監管核准迅速增加
      • 微波治療腋窩多汗、腋臭簡介
    • 任務
      • 產品召回及不良健康影響
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 溴病治療市場（依治療）

  • 肉毒桿菌
  • 抽脂手術
  • 外科手術

第7章 溴病治療市場（依適應症）

  • 紅斑
  • 擦爛
  • 腋癬
  • 2型糖尿病

第8章北美和南美溴病治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區溴病治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲溴病治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Biovencer Healthcare Pvt. Ltd.
  • Boehringer Ingelheim International GmbH
  • Galderma SA
  • Hikma Pharmaceuticals PLC
  • Ipsen Biopharmaceuticals, Inc.
  • Johnson & Johnson
  • Journey Medical Corp.
  • Medytox Inc.
  • Merz Pharma GmbH and Co. KGaA
  • Novartis AG
  • Pfizer Inc.
Product Code: MRR-742BD517C23C

The Bromhidrosis Disease Treatment Market was valued at USD 448.67 million in 2023, expected to reach USD 489.03 million in 2024, and is projected to grow at a CAGR of 9.39%, to USD 841.04 million by 2030.

Bromhidrosis, commonly known as body odor, arises from bacterial decomposition of apocrine and eccrine gland secretions. The scope of treatment involves topical and systemic therapies, lifestyle adjustments, and in advanced cases, surgical intervention. The necessity of bromhidrosis treatments is underscored by its significant psychosocial impact, which can affect personal relationships and professional interactions, fueling demand for effective solutions. The applications of such treatments extend from over-the-counter deodorants to prescription medications and advanced laser or surgical procedures, with end-use ranging across hospitals, specialty clinics, and home care settings. Key factors influencing market growth include rising awareness about personal hygiene, increased disposable income, and advancements in medical treatments. Potential opportunities lie in the development of personalized treatment regimens, leveraging biotechnology for novel therapeutics, and the incorporation of natural and organic ingredients in deodorant formulations to cater to the growing demand for eco-friendly products. However, the market faces limitations due to the presence of alternative treatments, side effects associated with certain medications, and cultural stigmas that may hinder patient engagement. Challenges also include regulatory hurdles and the high costs associated with advanced treatments like lasers and surgeries. Innovations in biotechnology could pave the way for new antibiotics targeting specific bacteria, enhancing the efficacy of bromhidrosis treatments. Furthermore, exploring areas like microbiome research and genetic predisposition could lead to breakthroughs in preventive care. The nature of the bromhidrosis treatment market is highly competitive, with companies continuously striving to innovate while maintaining affordability. For business growth, focusing on consumer education, expanding distribution networks, and fostering collaboration with dermatologists and healthcare providers will be crucial. Embracing digital marketing strategies and offering personalized care options could further enhance market penetration and consumer loyalty.

KEY MARKET STATISTICS
Base Year [2023] USD 448.67 million
Estimated Year [2024] USD 489.03 million
Forecast Year [2030] USD 841.04 million
CAGR (%) 9.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bromhidrosis Disease Treatment Market

The Bromhidrosis Disease Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cases of bromhidrosis and kidney and liver diseases
    • Rising investments in the clinical trials and R&D activities
    • Awareness about body odor issues
  • Market Restraints
    • High cost of treatment
  • Market Opportunities
    • Rapid proliferation of regulatory approvals of treatment products
    • Adoption of microwave-based therapy for axillary hyperhidrosis and bromhidrosis
  • Market Challenges
    • Product recalls and adverse health effects

Porter's Five Forces: A Strategic Tool for Navigating the Bromhidrosis Disease Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bromhidrosis Disease Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bromhidrosis Disease Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bromhidrosis Disease Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bromhidrosis Disease Treatment Market

A detailed market share analysis in the Bromhidrosis Disease Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bromhidrosis Disease Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bromhidrosis Disease Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bromhidrosis Disease Treatment Market

A strategic analysis of the Bromhidrosis Disease Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bromhidrosis Disease Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Biovencer Healthcare Pvt. Ltd., Boehringer Ingelheim International GmbH, Galderma S.A., Hikma Pharmaceuticals PLC, Ipsen Biopharmaceuticals, Inc., Johnson & Johnson, Journey Medical Corp., Medytox Inc., Merz Pharma GmbH and Co. KGaA, Novartis AG, and Pfizer Inc..

Market Segmentation & Coverage

This research report categorizes the Bromhidrosis Disease Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment, market is studied across Botox, Liposuction, and Surgery.
  • Based on Indication, market is studied across Erythrasma, Intertrigo, Trichomycosis Axillaries, and Type 2 Diabetes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of bromhidrosis and kidney and liver diseases
      • 5.1.1.2. Rising investments in the clinical trials and R&D activities
      • 5.1.1.3. Awareness about body odor issues
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid proliferation of regulatory approvals of treatment products
      • 5.1.3.2. Adoption of microwave-based therapy for axillary hyperhidrosis and bromhidrosis
    • 5.1.4. Challenges
      • 5.1.4.1. Product recalls and adverse health effects
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bromhidrosis Disease Treatment Market, by Treatment

  • 6.1. Introduction
  • 6.2. Botox
  • 6.3. Liposuction
  • 6.4. Surgery

7. Bromhidrosis Disease Treatment Market, by Indication

  • 7.1. Introduction
  • 7.2. Erythrasma
  • 7.3. Intertrigo
  • 7.4. Trichomycosis Axillaries
  • 7.5. Type 2 Diabetes

8. Americas Bromhidrosis Disease Treatment Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Bromhidrosis Disease Treatment Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Bromhidrosis Disease Treatment Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Biovencer Healthcare Pvt. Ltd.
  • 3. Boehringer Ingelheim International GmbH
  • 4. Galderma S.A.
  • 5. Hikma Pharmaceuticals PLC
  • 6. Ipsen Biopharmaceuticals, Inc.
  • 7. Johnson & Johnson
  • 8. Journey Medical Corp.
  • 9. Medytox Inc.
  • 10. Merz Pharma GmbH and Co. KGaA
  • 11. Novartis AG
  • 12. Pfizer Inc.

LIST OF FIGURES

  • FIGURE 1. BROMHIDROSIS DISEASE TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BROMHIDROSIS DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BROMHIDROSIS DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BROMHIDROSIS DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BROMHIDROSIS DISEASE TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTOX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY LIPOSUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ERYTHRASMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INTERTRIGO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TRICHOMYCOSIS AXILLARIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. BROMHIDROSIS DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. BROMHIDROSIS DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023